HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Preventing technology engagement fatigue for an aging population
HIMSS TV @ HIMSS25

Preventing technology engagement fatigue for an aging population

7:12

Sumit Nagpal, Cherish Health CEO, says his company's tool can help monitor patients who may not want to, or remember how to, enter their own data into a health app.

Read More
Read Less

HIMSS TV @ HIMSS25 - Similar Videos View more in HIMSS TV @ HIMSS25

5:33

Ambient AI is boosting clinician and patient satisfaction

According to Julie Frey, vice president of product at Wolters Kluwer, ambient AI tools are helping to restore doctors' human connections with patients and reducing their after-hours documentation burden.

Ambient AI is boosting clinician and patient satisfaction
According to Julie Frey, vice president of product at Wolters Kluwer, ambient AI tools are helping to restore doctors' human connections with patients and reducing their after-hours documentation burden.
5:33
7:00

AI can address clinician burden and burnout, but care must be taken

Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.

AI can address clinician burden and burnout, but care must be taken
Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.
7:00
3:58

Fighting cancer and genetic disease with 'living medicines'

Boro Dropuliç, executive director of Caring Cross, explains how gene and cell therapies "reprogram" the patient's own cells to stop the progression of certain cancers and genetic conditions, with remission rates of up to 92%.

Fighting cancer and genetic disease with 'living medicines'
Boro Dropuliç, executive director of Caring Cross, explains how gene and cell therapies "reprogram" the patient's own cells to stop the progression of certain cancers and genetic conditions, with remission rates of up to 92%.
3:58